These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8325974)

  • 1. In sickle disease, unlike wine, dry is not good.
    Schrier SL
    J Clin Invest; 1993 Jul; 92(1):1. PubMed ID: 8325974
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of sickle cell disease.
    Eaton JW; Hebbel RP
    Pathobiol Annu; 1981; 11():31-52. PubMed ID: 7036055
    [No Abstract]   [Full Text] [Related]  

  • 3. Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies.
    Hebbel RP
    N Engl J Med; 2000 Jun; 342(25):1910-2. PubMed ID: 10861330
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathophysiological-based approaches to treatment of sickle cell disease.
    Steinberg MH; Brugnara C
    Annu Rev Med; 2003; 54():89-112. PubMed ID: 12359829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lung in sickle cell disease.
    Knight J; Murphy TM; Browning I
    Pediatr Pulmonol; 1999 Sep; 28(3):205-16. PubMed ID: 10495338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorders of erythrocyte cation permeability and water content associated with hemolytic anemia.
    Mentzer WC; Clark MR
    Biomembranes; 1983; 11():79-118. PubMed ID: 6338953
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous viscous deformation of red blood cells in flow and their disturbance in sickle cell disease.
    Schmid-Schönbein H
    Blood Cells; 1982; 8(1):29-51. PubMed ID: 7115977
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of sickle cell anemia with induced hyponatremia.
    Rosa RM; Bierer BE; Bunn HF; Epstein FH
    Blood Cells; 1982; 8(2):329-35. PubMed ID: 7159756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal treatment of erythrocytes in sickle cell anemia: hemoglobin carbamylation.
    Diederich D; Curran M; Odenbaugh A; Diederich A; Core E
    Tex Rep Biol Med; 1980-1981; 40():313-22. PubMed ID: 7323976
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endothelium and sickle cell anemia, or how an amino acid mutation disturbs blood circulation].
    Wautier JL
    Rev Prat; 1999 Jan; 49(2):121-3. PubMed ID: 9989145
    [No Abstract]   [Full Text] [Related]  

  • 11. Erytrocyte adherence to endothelium as a determinant of vasocclusive severity in sickle cell disease.
    Hebbel RP; Boogaerts MA; Koresawa S; Jacob HS; Eaton JW; Steinberg MH
    Trans Assoc Am Physicians; 1980; 93():94-9. PubMed ID: 7245585
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythrophagocytosis as a determinant of hemolytic rate in sickle disease.
    Miller WJ; Hebbel RP
    Prog Clin Biol Res; 1984; 165():85-92. PubMed ID: 6504921
    [No Abstract]   [Full Text] [Related]  

  • 13. The biochemistry of resistance to malaria.
    Friedman MJ; Trager W
    Sci Am; 1981 Mar; 244(3):154-5, 158-64. PubMed ID: 6163210
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.
    Brugnara C; de Franceschi L; Alper SL
    J Clin Invest; 1993 Jul; 92(1):520-6. PubMed ID: 8326017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell disease--pathophysiology, clinical and diagnostic implications.
    Dorn-Beineke A; Frietsch T
    Clin Chem Lab Med; 2002 Nov; 40(11):1075-84. PubMed ID: 12521222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detours on the road to successful treatment of sickle cell anemia.
    Brewer GJ
    Perspect Biol Med; 1979; 22(2 Pt 1):250-72. PubMed ID: 379797
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular and cellular pathogenesis of hemoglobin SC disease.
    Bunn HF; Noguchi CT; Hofrichter J; Schechter GP; Schechter AN; Eaton WA
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7527-31. PubMed ID: 6961429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What dentists should know about sickle cell disease.
    Devine BP
    Tex Dent J; 2013 Nov; 130(11):1123-7. PubMed ID: 24400417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction.
    Ergul S; Brunson CY; Hutchinson J; Tawfik A; Kutlar A; Webb RC; Ergul A
    Am J Hematol; 2004 Jul; 76(3):245-51. PubMed ID: 15224360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyhemoglobin S polymer formation in sickle cells.
    Schechter AN; Noguchi CT; Rodgers GP
    Blood; 1986 Dec; 68(6):1415-6. PubMed ID: 3779105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.